Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prophylactic acetaminophen for ductus arteriosus closure in very preterm infants
IRCT20190305042935N1Phase 3Completed
- Sponsor
- Shahrekord University of Medical Sciences
- Start
- Feb 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of acetaminophen in patent ductus arteriosus (PDA) (2 arms), sponsored by Shahrekord University of Medical Sciences. Primary endpoint: Ductus arteriosus condition. Started Feb 2019; status: completed.
02
Drugs
acetaminophen
03
Conditions
patent ductus arteriosus (PDA)
Beyond the preview
Go deeper on IRCT20190305042935N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20190305042935N1.